サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514984

カタランチン市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Catharanthine Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
カタランチン市場：製品タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月24日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

カタランチン市場規模は2023年に8億2,332万米ドルとなり、2024年から2032年にかけてCAGR 3.5%で拡大

カタランチン市場-市場力学

一人当たりヘルスケア支出の増加とがん罹患率の増加が市場需要を促進

一人当たり医療費の増加とがん罹患率の増加が、カタランチン市場を促進すると予想されます。OECD保健統計によると、2019年、米国の1人当たり医療支出は1万米ドルを超え、オーストラリア、ニュージーランド、フランス、カナダ、英国などの国の2倍以上となっています。米国はまた、民間医療保険料への1人当たり支出でも4,092ドルとトップであり、2位のカナダより5倍以上高いです。一方、スウェーデンとノルウェーの民間支出は一人当たり100ドル以下です。米国の個人医療費は総医療費の40％を占め、0.3％から15％である諸外国よりかなり高いです。米国居住者の平均医療費自己負担額は1,122ドルで、フランスやニュージーランドの2倍以上です。このような医療費の増加、特に個人負担の増加は、効果的な治療に対する需要の高まりを浮き彫りにしています。さらに、世界のがん負担は劇的に増加しており、国際がん研究機関（IARC）は、2020年には新たに1,930万人が発症し、1,000万人が死亡すると報告しています。米国だけでも、国立がん研究所は2020年に180万6590人が新たにがんと診断され、60万6520人が死亡すると予測しています。このようながん罹患率の増加は、カタランチン由来のものを含む効果的な治療に対する緊急の必要性を浮き彫りにし、市場成長の原動力となっています。

カタランチン市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約3.5%のCAGRで毎年成長すると推定されます。

製品タイプ別では、硫酸キャタランチンが2023年に最大の市場シェアを示すと予測されています。

用途別では、医薬品が2023年の主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

カタランチン市場-セグメンテーション分析：

カタランチンの世界市場は、製品タイプ、用途、地域によって区分されます。

市場は製品タイプによって2つに分類される：カタランチン硫酸塩とカタランチン酒石酸塩です。2023年には、硫酸カタランチンセグメントがカタランチン市場で最大のシェアを占めました。硫酸カタランチンはビンブラスチン型アルカロイド前駆体であり、イオンチャネルの遮断と脱感作によりアセチルコリン受容体（AChR）を阻害することで抗腫瘍活性を示します。一方、酒石酸カタランチンはビンブラスチンとビンクリスチンを合成する前駆体として機能し、ビンクリスチンはビンブラスチンよりも神経毒性が強いです。これらのビンカアルカロイドは細胞周期特異的な抗腫瘍剤であり、チューブリンに結合して微小管への重合を妨げ、細胞分裂をメタフェースで停止させる。この分裂の阻害は細胞死につながります。小児化学療法薬として広く使われているビンクリスチンは、微小管形成を阻害することでアポトーシスを誘導し、血液悪性腫瘍と固形がんの両方を治療します。硫酸カタランチンと酒石酸カタランチンががん治療において重要な役割を果たしていることが、カタランチン市場の成長を牽引しています。

市場は用途によって3つのカテゴリーに分けられる：医薬品、飲食品、その他です。2023年も医薬品分野がカタランチン市場を独占しています。ビンブラスチン（VLB）やビンクリスチン（VCR）などの主要なインドールアルカロイドは、臨床的に不可欠な抗がん剤です。ビンブラスチンは、白血病、リンパ腫、非ホジキンリンパ腫、乳がん、精巣がんの治療に全身的に使用されます。ビンクリスチンは小児腫瘍学で頻繁に使用される化学療法薬として際立っており、血液悪性腫瘍や固形腫瘍に取り組んでいます。国際がん研究機関（IARC）によると、2020年には全世界で約1,930万人が新たにがんに罹患し、約1,000万人ががんに関連して死亡すると報告されています。これらの統計は、5,000万人以上の人々ががんと診断されてから5年以内の人生を歩んでいるという現実を浮き彫りにしています。その結果、カタランチンを原料とする治療に対する需要の高まりが予想され、予見可能な将来におけるそのような治療の必要性を反映しています。

カタランチン市場-地理的洞察

同市場の地理的範囲は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカです。これらの地域内では、特定の国が明確な市場セグメントを定義しています。2023年、北米はがんのような慢性疾患の有病率の上昇に牽引され、カタランチン市場で最大のシェアを占めました。International Journal of Environmental Research and Public Healthによると、世界の医薬品市場は大幅に拡大しており、インド、ブラジル、中国、インドネシア、メキシコ、ロシア、トルコなどのE7諸国が世界の医薬品売上高の5分の1を占めています。新興国市場では、主に米国における新製品と価格上昇が牽引し、5年間でブランド支出が2,980億米ドル増加すると予想されています。中国の医薬品市場も急成長しており、2023年には1,618億米ドルに達し、世界市場の30％のシェアを占めると予測されています。世界第2位の医薬品市場である中国の成長は、世界のカタランチン市場に大きな影響を与えています。

カタランチン市場-競合情勢：

カタランチン市場では、主要企業が競争力を維持するため、提携や研究の進展などの戦略的イニシアチブを採用しています。製薬会社、研究機関、農業団体との提携により、マダガスカル産のシソ科植物（Catharanthus roseus）由来のアルカロイドである高品質のカタランチンの安定供給が確保されています。これらのパートナーシップは、持続可能な栽培方法をサポートし、製薬業界への安定した原料供給源を確保しています。さらに、医薬品開発企業や学術研究者との提携は、特にがん治療やその他の疾患に対するカタランサンチンベースの医薬品の技術革新を推進しています。抽出方法、精製技術、合成経路に関する継続的な研究により、カタランサリンの生産効率と費用対効果がさらに向上し、企業はこの貴重な天然化合物の需要拡大に対応することができます。戦略的パートナーシップと研究の進展により、カタランチン市場の企業は市場のリーダーシップを維持し、医薬品開発のイノベーションを促進し、ヘルスケアの進歩に貢献することができます。

目次

第1章 カタランチン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 カタランチンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 カタランチン産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 カタランチン市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 カタランチン市場情勢

  • カタランチン市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 カタランチン市場：製品タイプ別

  • 概要
    • セグメントシェア分析
    • カタランチン硫酸塩
    • カタランチン酒石酸塩

第8章 カタランチン市場：用途別

  • 概要
    • セグメントシェア分析
    • 製薬
    • 飲食品
    • その他

第9章 カタランチン市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：カタランチン業界

  • 競争ダッシュボード
  • 企業プロファイル
    • AK Scientific Inc
    • Stanford Chemicals
    • Cayman Chemicals
    • Bio Vision Inc
    • Enzo Biochem Inc
    • Hainan Yueyang Biotech Co Ltd
    • Abcam
    • ChemFaces
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Catharanthine Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Catharanthine Market, by Product Type 2019-2032 (USD Million)
  • TABLE Catharanthine Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Catharanthine Market, by Application 2019-2032 (USD Million)
  • TABLE Catharanthine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Catharanthine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Catharanthine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Catharanthine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Catharanthine Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Catharanthine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Catharanthine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Catharanthine Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Catharanthine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Catharanthine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Catharanthine Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Catharanthine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Catharanthine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Catharanthine Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Catharanthine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Catharanthine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Catharanthine Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Catharanthine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Catharanthine Market share and leading players, 2023
  • FIGURE Europe Catharanthine Market share and leading players, 2023
  • FIGURE Asia Pacific Catharanthine Market share and leading players, 2023
  • FIGURE Latin America Catharanthine Market share and leading players, 2023
  • FIGURE Middle East and Africa Catharanthine Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Catharanthine Market share analysis by country, 2023
  • FIGURE Germany Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Catharanthine Market share analysis by country, 2023
  • FIGURE India Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Catharanthine Market share analysis by country, 2023
  • FIGURE Brazil Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Catharanthine Market share analysis by country, 2023
  • FIGURE Saudi Arabia Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Catharanthine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3111

REPORT HIGHLIGHT

Catharanthine Market size was valued at USD 823.32 Million in 2023, expanding at a CAGR of 3.5% from 2024 to 2032.

Catharanthine, a unique molecule found in the medicinal plant Catharanthus roseus (also known as Madagascar periwinkle), belongs to a class of compounds called monoterpenoid indole alkaloids. It boasts a complex structure, featuring a bridged ring system, a methyl ester group, and a tertiary amine. Notably, catharanthine serves as a crucial building block in the synthesis of vinblastine, a powerful chemotherapy drug used against various cancers. Catharanthine itself holds promise in the realm of medicine. Catharanthine sulfate, a specific salt form, exhibits anti-tumor activity, while catharanthine tartrate acts as a valuable starting material for the production of anti-cancer medications. This highlights the potential of catharanthine beyond its role as a precursor. Given its diverse applications in healthcare and pharmaceuticals, the market for catharanthine is anticipated to see continued growth.

Catharanthine Market- Market Dynamics

Rising per capita healthcare spending and increasing cancer incidence to propel market demand

Rising per capita healthcare spending and increasing cancer incidence are expected to propel the Catharanthine Market. According to OECD Health Statistics, in 2019, per capita health spending in the U.S. exceeded $10,000, more than double that of countries like Australia, New Zealand, France, Canada, and the U.K. The U.S. also leads in per capita spending on private health insurance premiums at $4,092, which is more than five times higher than Canada, the second-highest spender. In contrast, private spending in Sweden and Norway is less than $100 per capita. Private spending in the U.S. accounts for 40% of total health spending, significantly higher than other countries, where it ranges from 0.3% to 15%. The average U.S. resident paid $1,122 out-of-pocket for healthcare, more than double what residents of France and New Zealand pay. This increasing healthcare expenditure, especially in private spending, highlights the growing demand for effective treatments. Additionally, the global cancer burden has risen dramatically, with the (IARC) International Agency for Research on Cancer reporting 19.3 million new cases and 10 million cancer deaths in 2020. In the United States alone, the National Cancer Institute projected 1,806,590 new cancer diagnoses and 606,520 deaths in 2020. This rising incidence of cancer underscores the urgent need for effective treatments, including those derived from Catharanthine, thereby driving market growth.

Catharanthine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.5% over the forecast period (2024-2032)

Based on Product Type segmentation, catharanthine sulfate was predicted to show maximum market share in the year 2023

Based on Application segmentation, pharmaceutical was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Catharanthine Market- Segmentation Analysis:

The Global Catharanthine Market is segmented based on Product Type, Application, and Region.

The market is divided into two categories based on Product Type: Catharanthine sulfate and Catharanthine tartrate. In 2023, the catharanthine sulfate segment held the largest share of the Catharanthine Market. Catharanthine sulfate, a vinblastine-type alkaloid precursor, exhibits antitumor activity by inhibiting the acetylcholine receptor (AChR) through ion channel blocking and desensitization. Meanwhile, catharanthine tartrate serves as a precursor for synthesizing vinblastine and vincristine, with vincristine being more neurotoxic than vinblastine. These vinca alkaloids are cell cycle-specific antitumor agents that bind to tubulin, preventing its polymerization into microtubules, and arresting cell division at metaphase. This disruption of mitosis leads to cell death. Vincristine, a widely used pediatric chemotherapeutic agent, treats both hematologic malignancies and solid tumors by inducing apoptosis through interference with microtubule assembly. The pivotal roles of catharanthine sulfate and catharanthine tartrate in cancer treatment are driving growth in the Catharanthine Market.

The market is divided into three categories based on Application: Pharmaceutical, Food and Beverages and Others. The pharmaceutical segment also dominated the Catharanthine Market in 2023. Key indole alkaloids like vinblastine (VLB) and vincristine (VCR) are clinically essential anticancer agents. Vinblastine is used systemically for treating leukemias, lymphomas, non-Hodgkin lymphoma, breast cancer, and testicular cancer. Vincristine stands out as a frequently employed chemotherapy drug in pediatric oncology, tackling hematologic malignancies and solid tumors. According to the International Agency for Research on Cancer (IARC), approximately 19.3 million new cancer cases and roughly 10 million cancer-related deaths were documented worldwide in 2020. These statistics underscore the reality that over 50 million individuals are navigating life within five years of a cancer diagnosis. Consequently, there's a heightened demand anticipated for therapies derived from catharanthine, reflecting the need for such treatments in the foreseeable future.

Catharanthine Market- Geographical Insights

The geographic scope of this market encompasses North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, specific countries define distinct market segments. In 2023, North America held the largest share in the Catharanthine Market, driven by the rising prevalence of chronic diseases like cancer. According to the International Journal of Environmental Research and Public Health, the global pharmaceutical market has significantly increased, with E7 countries such as India, Brazil, China, Indonesia, Mexico, Russia, and Turkey accounting for one-fifth of global pharmaceutical sales. Developed markets are expected to see a $298 billion increase in brand spending over five years, primarily driven by new products and price increases in the U.S. China's pharmaceutical market is also growing rapidly, projected to reach $161.8 billion by 2023, holding a 30% share of the global market. As the world's second-largest pharmaceutical market, China's growth significantly influences the global Catharanthine Market.

Catharanthine Market- Competitive Landscape:

In the Catharanthine market, key players employ strategic initiatives such as partnerships and research advancements to maintain their competitive edge. Collaborations with pharmaceutical companies, research institutions, and agricultural organizations ensure a reliable supply of high-quality catharanthine, an alkaloid derived from the Madagascar periwinkle plant (Catharanthus roseus). These partnerships support sustainable cultivation practices, securing a consistent source of raw materials for the pharmaceutical industry. Moreover, alliances with drug developers and academic researchers drive innovation in catharanthine-based medications, especially for cancer treatment and other diseases. Continuous research into extraction methods, purification techniques, and synthesis pathways further enhances the efficiency and cost-effectiveness of catharanthine production, enabling companies to meet the growing demand for this valuable natural compound. Through strategic partnerships and research advancements, companies in the Catharanthine market can maintain market leadership, foster drug development innovation, and contribute to healthcare advancements.

Recent Developments:

As per the findings published in the 2022 volume of BioDesign Research on December 26, 2022, a research team from China, Zhejiang University has made a breakthrough by discovering a method for the biological synthesis of catharanthine and vindoline, the two pharmacological precursors of vinblastine. Previously, it was known that the biosynthesis of these precursors involves a 31-step reaction in Catharanthus roseus, a medicinal and ornamental plant. Inspired by this process, the research team genetically engineered Saccharomyces cerevisiae, commonly known as yeast, to produce vindoline and catharanthine. They then used chemical and biological coupling to convert these compounds into vinblastine.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CATHARANTHINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

AK Scientific Inc

Stanford Chemicals

Cayman Chemicals

Bio Vision Inc

Enzo Biochem Inc

Hainan Yueyang Biotech Co Ltd

Abcam

ChemFaces

Others

GLOBAL CATHARANTHINE MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

  • Catharanthine sulfate
  • Catharanthine tartrate

GLOBAL CATHARANTHINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical
  • Food and Beverages
  • Others

GLOBAL CATHARANTHINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Catharanthine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Catharanthine Market Snippet by Product Type
    • 2.1.2. Catharanthine Market Snippet by Application
    • 2.1.3. Catharanthine Market Snippet by Country
    • 2.1.4. Catharanthine Market Snippet by Region
  • 2.2. Competitive Insights

3. Catharanthine Key Market Trends

  • 3.1. Catharanthine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Catharanthine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Catharanthine Market Opportunities
  • 3.4. Catharanthine Market Future Trends

4. Catharanthine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Catharanthine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Catharanthine Market Landscape

  • 6.1. Catharanthine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Catharanthine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Catharanthine sulfate
    • 7.1.3. Catharanthine tartrate

8. Catharanthine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Pharmaceutical
    • 8.1.3. Food and Beverages
    • 8.1.4. Others

9. Catharanthine Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Catharanthine Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Catharanthine Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Catharanthine Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Catharanthine Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Catharanthine Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Catharanthine Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. AK Scientific Inc
    • 10.2.2. Stanford Chemicals
    • 10.2.3. Cayman Chemicals
    • 10.2.4. Bio Vision Inc
    • 10.2.5. Enzo Biochem Inc
    • 10.2.6. Hainan Yueyang Biotech Co Ltd
    • 10.2.7. Abcam
    • 10.2.8. ChemFaces
    • 10.2.9. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us